Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

Thomas W. Geisbert; Lisa E. Hensley; Peter B. Jahrling; Thomas Larsen; Joan B. Geisbert; Jason Paragas; Howard A. Young; T. Fredeking; William E. Rote; George P. Vlasuk

doi:10.1016/s0140-6736(03)15012-x

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

Thomas W. Geisbert(United States Army Medical Research Institute of Infectious Diseases), Lisa E. Hensley(United States Army Medical Research Institute of Infectious Diseases), Peter B. Jahrling(United States Army Medical Research Institute of Infectious Diseases), Thomas Larsen(United States Army Medical Research Institute of Infectious Diseases), Joan B. Geisbert(United States Army Medical Research Institute of Infectious Diseases), Jason Paragas(United States Army Medical Research Institute of Infectious Diseases), Howard A. Young(Frederick National Laboratory for Cancer Research), T. Fredeking, William E. Rote, George P. Vlasuk

The Lancet

December 1, 2003

10.1016/s0140-6736(03)15012-x

Cited by 381Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis